CD6 and neoplasm: In this process, the absence of CAF_CCL21 also impairs complement-dependent CR2 activation of B_CD74, while the dysfunction of B_CD74 weakens CD6-dependent activation of CD8+ T cells, thereby attenuating their involvement in anti-tumor immunity.